In COVID-19, these activated pathways converge, resulting in production of complement anaphylatoxins C3a and C5a, which are known to increase immune cell recruitment, exacerbate endothelial damage by promoting release of reactive oxygen species, and exert deleterious pro-thrombotic effects [152,162,163]. Here, C3 is linked to COVID-19.